Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Mol Genet ; 15(8): 1329-41, 2006 Apr 15.
Article in English | MEDLINE | ID: mdl-16537572

ABSTRACT

The mammalian Nell1 gene encodes a protein kinase C-beta1 (PKC-beta1) binding protein that belongs to a new class of cell-signaling molecules controlling cell growth and differentiation. Over-expression of Nell1 in the developing cranial sutures in both human and mouse induces craniosynostosis, the premature fusion of the growing cranial bone fronts. Here, we report the generation, positional cloning and characterization of Nell1(6R), a recessive, neonatal-lethal point mutation in the mouse Nell1 gene, induced by N-ethyl-N-nitrosourea. Nell1(6R) has a T-->A base change that converts a codon for cysteine into a premature stop codon [Cys(502)Ter], resulting in severe truncation of the predicted protein product and marked reduction in steady-state levels of the transcript. In addition to the expected alteration of cranial morphology, Nell1(6R) mutants manifest skeletal defects in the vertebral column and ribcage, revealing a hitherto undefined role for Nell1 in signal transduction in endochondral ossification. Real-time quantitative reverse transcription-PCR assays of 219 genes showed an association between the loss of Nell1 function and reduced expression of genes for extracellular matrix (ECM) proteins critical for chondrogenesis and osteogenesis. Several affected genes are involved in the human cartilage disorder Ehlers-Danlos Syndrome and other disorders associated with spinal curvature anomalies. Nell1(6R) mutant mice are a new tool for elucidating basic mechanisms in osteoblast and chrondrocyte differentiation in the developing skull and vertebral column and understanding how perturbations in the production of ECM proteins can lead to anomalies in these structures.


Subject(s)
Calcium-Binding Proteins/genetics , Extracellular Matrix Proteins/metabolism , Glycoproteins/genetics , Skull/abnormalities , Spine/abnormalities , Abnormalities, Drug-Induced/metabolism , Amino Acid Sequence , Animals , Base Sequence , Calcification, Physiologic/genetics , Calcium-Binding Proteins/metabolism , Cell Adhesion Molecules/metabolism , Chondrogenesis , Cysteine/genetics , Cysteine/metabolism , Female , Glycoproteins/metabolism , Male , Mice , Mice, Inbred Strains , Molecular Sequence Data , Osteogenesis , Point Mutation , Signal Transduction , Tyrosine/genetics , Tyrosine/metabolism
2.
BMC Genomics ; 6: 164, 2005 Nov 21.
Article in English | MEDLINE | ID: mdl-16300676

ABSTRACT

BACKGROUND: Analysis of an allelic series of point mutations in a gene, generated by N-ethyl-N-nitrosourea (ENU) mutagenesis, is a valuable method for discovering the full scope of its biological function. Here we present an efficient gene-driven approach for identifying ENU-induced point mutations in any gene in C57BL/6J mice. The advantage of such an approach is that it allows one to select any gene of interest in the mouse genome and to go directly from DNA sequence to mutant mice. RESULTS: We produced the Cryopreserved Mutant Mouse Bank (CMMB), which is an archive of DNA, cDNA, tissues, and sperm from 4,000 G1 male offspring of ENU-treated C57BL/6J males mated to untreated C57BL/6J females. Each mouse in the CMMB carries a large number of random heterozygous point mutations throughout the genome. High-throughput Temperature Gradient Capillary Electrophoresis (TGCE) was employed to perform a 32-Mbp sequence-driven screen for mutations in 38 PCR amplicons from 11 genes in DNA and/or cDNA from the CMMB mice. DNA sequence analysis of heteroduplex-forming amplicons identified by TGCE revealed 22 mutations in 10 genes for an overall mutation frequency of 1 in 1.45 Mbp. All 22 mutations are single base pair substitutions, and nine of them (41%) result in nonconservative amino acid substitutions. Intracytoplasmic sperm injection (ICSI) of cryopreserved spermatozoa into B6D2F1 or C57BL/6J ova was used to recover mutant mice for nine of the mutations to date. CONCLUSIONS: The inbred C57BL/6J CMMB, together with TGCE mutation screening and ICSI for the recovery of mutant mice, represents a valuable gene-driven approach for the functional annotation of the mammalian genome and for the generation of mouse models of human genetic diseases. The ability of ENU to induce mutations that cause various types of changes in proteins will provide additional insights into the functions of mammalian proteins that may not be detectable by knockout mutations.


Subject(s)
Genetic Techniques , Mutagenesis , Oligonucleotide Array Sequence Analysis/methods , Animals , Crosses, Genetic , Cryopreservation , DNA/metabolism , DNA Mutational Analysis , DNA, Complementary/metabolism , Databases, Genetic , Ethylnitrosourea/pharmacology , Female , Genotype , Germ-Line Mutation , Homozygote , Male , Mice , Mice, Inbred C57BL , Models, Genetic , Mutagens , Mutation , Phenotype , Point Mutation , Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Sperm Injections, Intracytoplasmic , Spermatozoa/metabolism , Tissue Distribution
3.
Mamm Genome ; 16(8): 555-66, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16180137

ABSTRACT

We have used the new high-throughput mutation-scanning technique temperature-gradient capillary electrophoresis (TGCE) for the identification of point mutations induced by N-ethyl-N-nitrosourea (ENU) in the mouse genome. TGCE detects the presence of heteroduplex molecules formed between a wild-type gene segment and the corresponding homologous segment containing an induced mutation or a naturally occurring single nucleotide polymorphism (SNP). Partially denatured heteroduplex molecules are resolved from homoduplexes by virtue of their differential mobilities during capillary electrophoresis conducted in a finely controlled temperature gradient. Simultaneous heteroduplex analysis of 96 amplicons ranging from 150 to 600 bp in size is achieved in approximately 45 min without the need for predetermining the melting profile of each fragment. Initially, we exploited known mouse mutations to develop TGCE protocols for analyzing unpurified PCR samples amplified from crude tail-DNA preparations. TGCE was then applied to the rapid identification of three new ENU-induced mutations recovered from regional mutagenesis screens of a segment of mouse Chromosome 7. Enzyme assays and quantitative reverse transcription-PCR (qRT-PCR) methods validated these new mutations. Our data demonstrate that rapid mutation scanning with TGCE, followed by sequence verification only of detected positives, is an efficient approach to the identification of point mutations in the mouse genome.


Subject(s)
Chromosomes, Mammalian/genetics , DNA Mutational Analysis , Ethylnitrosourea/pharmacology , Mutagenesis/drug effects , Point Mutation/genetics , Animals , Base Sequence , Chromatography, High Pressure Liquid , Electrophoresis, Capillary , Heteroduplex Analysis , Isoenzymes/genetics , L-Lactate Dehydrogenase/genetics , Mice , Mice, Inbred BALB C , Oxygenases/genetics , Phenotype , Serum Amyloid A Protein/genetics
4.
Am J Hum Genet ; 73(6): 1459-64, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14624391

ABSTRACT

Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. Mutations in the gene KRIT1 are responsible for type 1 CCM (CCM1). We report that a novel gene, MGC4607, exhibits eight different mutations in nine families with type 2 CCM (CCM2). MGC4607, similar to the KRIT1 binding partner ICAP1alpha, encodes a protein with a phosphotyrosine-binding domain. This protein may be part of the complex pathway of integrin signaling that, when perturbed, causes abnormal vascular morphogenesis in the brain, leading to CCM formation.


Subject(s)
Brain/embryology , Central Nervous System Vascular Malformations/genetics , Genetic Predisposition to Disease , Integrins/metabolism , Signal Transduction , Blotting, Northern , Chromosome Mapping , Humans , Integrins/genetics , KRIT1 Protein , Magnetic Resonance Imaging , Microtubule-Associated Proteins/genetics , Morphogenesis , Mutation/genetics , Proto-Oncogene Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
5.
Environ Mol Mutagen ; 41(2): 111-20, 2003.
Article in English | MEDLINE | ID: mdl-12605380

ABSTRACT

N-Hydroxymethylacrylamide (NHMA), a mouse carcinogen inactive in the Salmonella assay and mouse micronucleus (MN) assay, was tested for reproductive effects in a mouse continuous breeding study. In that study, increased embryonic deaths were observed after 13 weeks exposure of parental animals to NHMA via drinking water (highest dose, 360 ppm); the results indicated the possible induction of chromosome damage in germ cells of treated males. An additional mouse MN test was conducted using a 31-day treatment period to better match the dosing regimen used in the breeding study; the results were negative. Additional studies were conducted to explore the germ cell activity of NHMA. A male mouse dominant lethal study was conducted using a single intraperitoneal injection of 150 mg/kg NHMA; the results were negative. A follow-up study was conducted using fractionated dosing, 50 mg/kg/day for 5 days; again, no increase in dominant lethal mutations was observed. NHMA (180-720 ppm) was then administered to male mice in drinking water for 13 weeks, during which three sets of matings occurred. Two weeks after mating, females were killed and the uterine contents were analyzed. Large, dose-related increases in dominant lethal mutations were observed with increasing length of exposure. The magnitude of the increases stabilized after 8 weeks of treatment. However, the frequency of micronucleated peripheral blood erythrocytes was not elevated in mice treated for 13 weeks with NHMA in drinking water. Thus, NHMA appears to be unique in inducing genetic damage in germ cells but not somatic cells of male mice.


Subject(s)
Acrylamides/toxicity , Bone Marrow/drug effects , Chromosome Aberrations , Germ Cells/drug effects , Mutagens/toxicity , Pregnancy, Animal/drug effects , Acrylamides/administration & dosage , Acrylamides/urine , Animals , Bone Marrow/pathology , Erythrocytes , Female , Genes, Dominant , Genes, Lethal , Injections, Intraperitoneal , Male , Mice , Mice, Inbred Strains , Micronucleus Tests , Mutagenicity Tests , Pregnancy , Water
6.
Am J Hum Genet ; 71(5): 1189-94, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12355402

ABSTRACT

We have identified a missense mutation in the motor domain of the neuronal kinesin heavy chain gene KIF5A, in a family with hereditary spastic paraplegia. The mutation occurs in the family in which the SPG10 locus was originally identified, at an invariant asparagine residue that, when mutated in orthologous kinesin heavy chain motor proteins, prevents stimulation of the motor ATPase by microtubule-binding. Mutation of kinesin orthologues in various species leads to phenotypes resembling hereditary spastic paraplegia. The conventional kinesin motor powers intracellular movement of membranous organelles and other macromolecular cargo from the neuronal cell body to the distal tip of the axon. This finding suggests that the underlying pathology of SPG10 and possibly of other forms of hereditary spastic paraplegia may involve perturbation of neuronal anterograde (or retrograde) axoplasmic flow, leading to axonal degeneration, especially in the longest axons of the central nervous system.


Subject(s)
Kinesins/genetics , Mutation , Spastic Paraplegia, Hereditary/genetics , Amino Acid Sequence , Animals , Axons/metabolism , Female , Humans , Male , Molecular Sequence Data , Pedigree , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...